Jodi Regts | VP, Corporate Affairs & IR |
Dr. Simon Pimstone | CEO |
Ian Mortimer | President and CFO |
Stephen Willey | Stifel |
Good day, ladies and gentlemen, and welcome to the Q2 2018 Xenon Pharmaceuticals Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we’ll conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] As a reminder, this conference may be recorded. I would now like to turn the conference over to your host, Ms.